Phenotype-treatment dissociation in psoriatic and nonpsoriatic peripheral spondyloarthritis: a propensity score-matched analysis with novel treatment intensity metrics [0.03%]
银屑病性外周型轴肿关节炎和非银屑病性外周型轴肿关节炎的表型与治疗差异：一项新型治疗强度指标的倾向分值匹配分析
Yesim Erez,Semih Gulle,Tuba Yuce Inel et al.
Yesim Erez et al.
Objective: To compare the clinical phenotype, treatment intensity, and outcomes of psoriatic arthritis (PsA) and nonpsoriatic peripheral spondyloarthritis (pSpA) using propensity score-matched real-world data and reproduc...
COVID-19 outcomes among vaccinated and unvaccinated patients receiving disease-modifying antirheumatic drugs and biologic therapies: a retrospective multihospital cohort study [0.03%]
接受疾病改善抗风湿药物和生物制剂的新冠疫苗接种者与未接种者的预后：一项基于多院系队列的回顾性研究
Dat Le,Yijin Wert
Dat Le
Introduction/objectives: Patients receiving disease-modifying antirheumatic drugs (DMARDs) and biologic therapies were underrepresented in initial COVID-19 vaccine trials, limiting understanding of vaccine effectiveness i...
Multicenter Study
Clinical rheumatology. 2026 Oct;45(10):5989-5997. DOI:10.1007/s10067-026-08371-w 2026
Peripheral bone erosion and atlantoaxial instability as factors associated with pannus formation in rheumatoid arthritis: a cross-sectional risk stratification study [0.03%]
外周骨侵蚀和寰枢椎不稳定在类风湿关节炎滑膜炎中的相关性：一项基于风险分层的横断面研究
Jun-Hyun Hwang,Je Il Ryu
Jun-Hyun Hwang
Objectives: Clinical and radiologic predictors of atlantoaxial pannus formation in rheumatoid arthritis (RA) remain unidentified. We aimed to develop a risk stratification model using routinely collected data. ...
Circulating levels of TL1A and its decoy receptor DcR3 in systemic sclerosis [0.03%]
系统性硬化症患者中TL1A和其诱饵受体DcR3的循环水平测定
Vassiliki Poulia,Nikolaos I Vlachogiannis,Aikaterini-Paraskevi Avdi et al.
Vassiliki Poulia et al.
Introduction/objective: Tumor necrosis factor-like cytokine 1A (TL1A, TNFSF15) is a profibrotic and proinflammatory cytokine. Experimental evidence implicates TL1A-mediated interactions in interstitial lung disease (ILD);...
Digital physical-activity engagement and 12-week patient-reported outcomes in inflammatory arthritis: a retrospective real-world cohort study [0.03%]
数字化身体活动参与和炎性关节炎患者的12周自我报告结局：一项回顾性真实世界队列研究
Dmytro Fedkov,Daria Koliadenko,Liubov Petelytska et al.
Dmytro Fedkov et al.
Background: Physical activity is a key component of inflammatory arthritis (IA) management, yet real-world evidence on digital exercise-support tools remains limited. ...
Comment on "Awareness of rheumatoid arthritis symptoms and complications among the Jordanians" [0.03%]
对“约旦人对类风湿关节炎症状和并发症的认知”的评论
M Vimal Kumar,Lakshmi Nagalingam,Krishna Prasanth Baalann
M Vimal Kumar
Anti-centromere antibody positivity: a spectrum of clinical diagnoses and immunological patterns in a large patient cohort [0.03%]
抗着丝点抗体阳性：大型患者队列中的临床诊断和免疫学特征谱系
Yadan Li,Guangzhi Xiao,Rongrong Dou et al.
Yadan Li et al.
Objective: Anti-centromere antibody (ACA) positivity is recognized in diverse autoimmune diseases beyond systemic sclerosis (SSc). This study aimed to comprehensively characterize the clinical spectrum and serological pro...
Real-world effectiveness of tofacitinib in monotherapy or in combination with csDMARDs in patients with rheumatoid arthritis: A collaboration between Dutch registries (TOFADUDAP study) [0.03%]
托法替尼单药或联合传统合成改善病情抗风湿药治疗类风湿关节炎的疗效：荷兰登记处合作研究（TOFADUDAP 研究）
Isabell S Nevins,Herman Kasper Glas,Floor Reimann et al.
Isabell S Nevins et al.
Objective: To compare real-world effectiveness of tofacitinib monotherapy to adalimumab monotherapy, and tofacitinib and adalimumab in combination with csDMARDs in Rheumatoid Arthritis (RA) subgroups. ...
Risk factors for infection in rheumatoid arthritis patients treated with tocilizumab: an observational study highlighting hydroxychloroquine use [0.03%]
托珠单抗治疗类风湿关节炎患者感染的危险因素：一项观察性研究，重点关注羟氯喹使用情况
Sheng Zhao,Houhui Jiang,Yuxin Yan et al.
Sheng Zhao et al.
Introduction: Infections remain a major safety concern in patients with rheumatoid arthritis (RA) receiving tocilizumab (TCZ). This study evaluated clinical risk factors for clinically significant infections in a real-wor...
Observational Study
Clinical rheumatology. 2026 Oct;45(10):6061-6070. DOI:10.1007/s10067-026-08357-8 2026
Association of hematological inflammatory indices with disease activity and interstitial lung disease in systemic sclerosis [0.03%]
血液炎症指标与系统性硬化症疾病活动及间质性肺病的关系研究
Irem Şahinoğlu,Sadettin Uslu
Irem Şahinoğlu
Introduction: The current study evaluates the association of hematological inflammatory indices with disease activity and interstitial lung disease (ILD) in patients with systemic sclerosis (SSc), with particular emphasis...